Betz Stephen F.
Chief Scientific Officer
Betz Stephen F. has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Betz Stephen F. is listed as Chief Scientific Officer at Crinetics Pharmaceuticals, Inc. Inside the rolling window, Betz Stephen F. reported no open-market purchases and 1 open-market sale totaling $397K in CRNX.
Companies traded
Other insiders at CRNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$397K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Betz Stephen F. made?
Betz Stephen F. has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Betz Stephen F. trade?
Betz Stephen F. has filed SEC Form 4 disclosures for 1 company, including CRNX.
When was Betz Stephen F.'s most recent SEC Form 4 filing?
Betz Stephen F.'s most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Betz Stephen F.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Betz Stephen F. is listed as Chief Scientific Officer.
What is Betz Stephen F.'s total buy and sell value in the current window?
Inside the rolling retention window, Betz Stephen F. bought $0 and sold $397K based on SEC Form 4 filings.
What was Betz Stephen F.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,612 CRNX shares on 2026-03-16, worth $397K, per SEC Form 4 filings.